Seth Harmon - Chief Financial Officer at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
VRDN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Seth Harmon since 10/8/2024

Holdings reported by Seth Harmon for Viridian Therapeutics, Inc.\DE

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 25.1K $587K $23.41 Mar 3, 2025 Direct Common Stock
Stock Option (Right to Buy) 150K Mar 3, 2025 Direct Common Stock

Transactions reported by Seth Harmon for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.